Liebl, A., Davidson, J., Mersebach, H., Dykiel, P., Tack, C. J., & Heise, T. (2013). A Novel Insulin Combination of Insulin Degludec and Insulin Aspart Achieves a More Stable Overnight Glucose Profile than Insulin Glargine: Results from Continuous Glucose Monitoring in a Proof-of-Concept Trial. Diabetes Technology Society.
Citação norma ChicagoLiebl, Andreas, Jaime Davidson, Henriette Mersebach, Patrik Dykiel, Cees J. Tack, and Tim Heise. A Novel Insulin Combination of Insulin Degludec and Insulin Aspart Achieves a More Stable Overnight Glucose Profile Than Insulin Glargine: Results From Continuous Glucose Monitoring in a Proof-of-Concept Trial. Diabetes Technology Society, 2013.
ציטוט MLALiebl, Andreas, et al. A Novel Insulin Combination of Insulin Degludec and Insulin Aspart Achieves a More Stable Overnight Glucose Profile Than Insulin Glargine: Results From Continuous Glucose Monitoring in a Proof-of-Concept Trial. Diabetes Technology Society, 2013.